Global analysis of neurological disease: burden and benefit.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Abnormal Functional Network Centrality and Causal Connectivity in Migraine Without Aura: A Resting-State fMRI Study.Brain and behavior · 2025
   Article
2. Inhibition of YIPF2 Improves the Vulnerability of Oligodendrocytes to Human Islet Amyloid Polypeptide.Neuroscience bulletin · 2024
   Article
3. A Promising Approach: Magnetic Nanosystems for Alzheimer's Disease Theranostics.Pharmaceutics · 2023
   Review
4. Modeling human neurodevelopmental diseases with brain organoids.Cell regeneration (London, England) · 2022
   Review
5. Effect of ultra‑wide‑band electromagnetic pulses on blood‑brain barrier permeability in rats.Molecular medicine reports · 2020
   Article
6. In vitro modeling for inherited neurological diseases using induced pluripotent stem cells: from 2D to organoid.Archives of pharmacal research · 2020
   Review
7. An "all-wheel drive" proposal to accelerate clinical research in common and rare neurological diseases.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
   Review
8. Receptor variants and the development of centrally acting medications
.Dialogues in clinical neuroscience · 2019
   Article

Corrections and comments

• Comment on
  Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.2017

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as